The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...

The Gonzales Lab at UNR Med, led by Albert Gonzales, Ph.D., assistant professor of physiology and cell biology, spearheaded ...

The research illustrated “substantial benefits” of enhanced optometry services in community practices handling conditions ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

Eye Care Supplement MarketThe global eye care supplement market is on the cusp of significant expansion, with leading market analysis authority Future Market Insights (FMI) predicting a valuation of ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as ... Read More The ...

Leerink Partners analyst Marc Goodman has maintained their bullish stance on OPT stock, giving a Buy rating yesterday.Invest with Confidence: ...

Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a Principal Investigator in PRISM, at Angiogenesis, ...

Align ENT + Allergy is thrilled to partner with Greco MD and Timothy M. Greco, MD, FACS, a double-board-certified facial plastic and reconstructive surgeon with close to 30 years of experience in the ...

Equality Health, a trailblazing value-based care (VBC) enabler with a Medicaid-first care model, continues to lead the charge in advancing health equity and improving outcomes for underserved ...